ArticleFrontiers in immunology2023

Safety of JAK and IL-6 inhibitors in patients with rheumatoid arthritis: a multicenter cohort study.

Shuhei Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.